scholarly article | Q13442814 |
P2093 | author name string | Elisabeth R Barton | |
Becky K Brisson | |||
SooHyun Park | |||
Janelle Spinazzola | |||
P2860 | cites work | Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice | Q72223472 |
IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice | Q73739705 | ||
Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats | Q74510959 | ||
Characterization of a rabbit antihuman mechano growth factor (MGF) polyclonal antibody against the last 24 amino acids of the E domain | Q81039886 | ||
A synthetic mechano growth factor E Peptide enhances myogenic precursor cell transplantation success | Q81227019 | ||
The IGF-I splice variant MGF increases progenitor cells in ALS, dystrophic, and normal muscle | Q24307354 | ||
Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function | Q24642759 | ||
Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes | Q28345343 | ||
Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) | Q29619910 | ||
New insulin-like growth factor (IGF)-precursor sequences from mammalian genomes: the molecular evolution of IGFs and associated peptides in primates | Q31160029 | ||
Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle | Q31929653 | ||
Post-translational processing of insulin-like growth factors | Q33607311 | ||
Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration | Q33735493 | ||
The insulin-like growth factor (IGF)-I E-peptides are required for isoform-specific gene expression and muscle hypertrophy after local IGF-I production | Q33841223 | ||
Sequence of cDNA encoding human insulin-like growth factor I precursor | Q34055481 | ||
Insulin-like growth factor-I E-peptide activity is dependent on the IGF-I receptor | Q34429527 | ||
Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle | Q34787562 | ||
Self-complementary AAV vectors; advances and applications | Q34804660 | ||
Lack of myostatin results in excessive muscle growth but impaired force generation | Q35629418 | ||
Deletion of muscle GRP94 impairs both muscle and body growth by inhibiting local IGF production | Q36183694 | ||
Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues | Q36457963 | ||
E-peptides control bioavailability of IGF-1. | Q36459287 | ||
The pro-forms of insulin-like growth factor I (IGF-I) are predominant in skeletal muscle and alter IGF-I receptor activation | Q36628478 | ||
Loss of muscle strength during aging studied at the gene level | Q36932676 | ||
The insulin-like growth factor (IGF)-I E-peptides modulate cell entry of the mature IGF-I protein | Q37327278 | ||
Mature IGF-I excels in promoting functional muscle recovery from disuse atrophy compared with pro-IGF-IA. | Q37679375 | ||
Fiber-type discrimination in disuse and glucocorticoid-induced atrophy | Q37945510 | ||
Sequences of liver cDNAs encoding two different mouse insulin-like growth factor I precursors | Q40419087 | ||
Is functional hypertrophy and specific force coupled with the addition of myonuclei at the single muscle fiber level? | Q40472290 | ||
Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation | Q40721113 | ||
Monoclonal antibodies to the carboxy-terminal Ea sequence of pro-insulin-like growth factor-IA (proIGF-IA) recognize proIGF-IA secreted by IM9 B-lymphocytes | Q40794909 | ||
Isometric and eccentric force generation assessment of skeletal muscles isolated from murine models of muscular dystrophies | Q41152126 | ||
Growth hormone and the insulin-like growth factor system in myogenesis | Q41192757 | ||
Contractile properties of skeletal muscles from young, adult and aged mice | Q41421042 | ||
Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation | Q43297220 | ||
Expression and Splicing of the Insulin‐Like Growth Factor Gene in Rodent Muscle is Associated with Muscle Satellite (stem) Cell Activation following Local Tissue Damage | Q44401232 | ||
Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. | Q44904396 | ||
Structural and functional characteristics of the Val44Met insulin-like growth factor I missense mutation: correlation with effects on growth and development | Q45171483 | ||
Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro. | Q45945739 | ||
Mechano-growth factor peptide, the COOH terminus of unprocessed insulin-like growth factor 1, has no apparent effect on myoblasts or primary muscle stem cells. | Q46007172 | ||
Antiserum developed for the E peptide region of insulin-like growth factor IA prohormone recognizes a serum protein by both immunoblot and radioimmunoassay. | Q46031705 | ||
Viral expression of insulin-like growth factor-I isoforms promotes different responses in skeletal muscle | Q46913649 | ||
Distribution and regulation of rat insulin-like growth factor I messenger ribonucleic acids encoding alternative carboxyterminal E-peptides: evidence for differential processing and regulation in liver | Q68511364 | ||
Alternative splicing produces messenger RNAs encoding insulin-like growth factor-I prohormones that are differentially glycosylated in vitro | Q68592945 | ||
P433 | issue | 8 | |
P921 | main subject | preproinsulin | Q7240673 |
P304 | page(s) | E965-74 | |
P577 | publication date | 2014-02-25 | |
P1433 | published in | American Journal of Physiology - Endocrinology and Metabolism | Q15765671 |
P1476 | title | Viral expression of insulin-like growth factor I E-peptides increases skeletal muscle mass but at the expense of strength | |
P478 | volume | 306 |
Q92889289 | Effects of IGF-1 isoforms on muscle growth and sarcopenia |
Q40218139 | Effects of sustained exercise on GH-IGFs axis in gilthead sea bream (Sparus aurata). |
Q92022211 | Functional muscle hypertrophy by increased insulin-like growth factor 1 does not require dysferlin |
Q50916181 | Human IGF-I Eb-peptide induces cell attachment and lamellipodia outspread of metastatic breast carcinoma cells (MDA-MB-231). |
Q90482471 | Insulin-Like Growth Factor I Regulation and Its Actions in Skeletal Muscle |
Q54309806 | Lack of the serum- and glucocorticoid-inducible kinase SGK1 improves muscle force characteristics and attenuates fibrosis in dystrophic mdx mouse muscle. |
Q35083679 | Localized delivery of mechano-growth factor E-domain peptide via polymeric microstructures improves cardiac function following myocardial infarction |
Q26825444 | Optimizing IGF-I for skeletal muscle therapeutics |
Q28082188 | Role of IGF-I signaling in muscle bone interactions |
Search more.